Literature DB >> 10861340

Evaluation of ischemic injury during liver procurement from non-heart-beating donors.

J C García-Valdecasas1, J Tabet, R Valero, R Deulofeu, P Taurá, R Rull, L Capdevila, A Cifuentes, F X González, M Net, J Beltran, M A López-Boado, J Palacin, F García, J Visa.   

Abstract

UNLABELLED: The aim of this study was to assess liver viability after different periods of cardiac arrest and the predictive value of two markers of ischemia-reperfusion injury.
METHODS: A pig liver transplantation model of non-heart-beating donors was studied. Four donor groups were designed; three groups were submitted to different periods of cardiac arrest (20, 30 and 40 min), and the fourth group served as the control group (without cardiac arrest). In the non-heart-beating donor groups, normothermic recirculation was established 30 min prior to total body cooling. Aminotransferase, alpha-glutathione-S-transferase, and hyaluronic acid determinations as well as liver biopsies, were serially performed.
RESULTS: Although hepatocellular function could be preserved after 40 min of cardiac arrest, histological lesions at 5 days were considered irreversible due to the presence of a necrotic biliary tract. An overall significant relationship was found between the time period of cardiac arrest (20, 30 or 40 min) and the levels of hyaluronic acid (p = 0.004) or alpha-glutathione-S-transferase (p = 0.01) obtained during liver procurement and transplantation.
CONCLUSIONS: The period of cardiac arrest is the determinant factor of liver viability after liver transplantation from non-heart-beating donors. As early markers of endothelial or hepatocellular damage, hyaluronic acid or alpha-glutathione-S-transferase levels may help to evaluate the ischemic injury of a potential donor. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10861340     DOI: 10.1159/000008724

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

1.  Postmortem MR diffusion-weighted imaging of the liver: time-behavior of the hepatic apparent diffusion coefficient in the early death interval.

Authors:  Sarah Keller; Tony M Schmidt; Anne Catherine Kim; Roland Fischer; Axel Heinemann; Gerhard Adam; Jin Yamamura
Journal:  Int J Legal Med       Date:  2017-09-14       Impact factor: 2.686

2.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 3.  Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation.

Authors:  Moustafa Mabrouk Mourad; Abdullah Algarni; Christos Liossis; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation.

Authors:  Yang Tian; Jingcheng Wang; Wei Wang; Yuan Ding; Zhongquan Sun; Qiyi Zhang; Yan Wang; Haiyang Xie; Sheng Yan; Shusen Zheng
Journal:  Stem Cell Res Ther       Date:  2016-10-27       Impact factor: 6.832

Review 5.  Non heart-beating donors in England.

Authors:  Eleazar Chaib
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

6.  Impact of machine perfusion of the liver on post-transplant biliary complications: A systematic review.

Authors:  Yuri L Boteon; Amanda Pcs Boteon; Joseph Attard; Lorraine Wallace; Ricky H Bhogal; Simon C Afford
Journal:  World J Transplant       Date:  2018-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.